Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
202 | 3 | DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES | 52563 |
628 | 2 | SGLT2 INHIBITOR//METFORMIN//DPP 4 INHIBITOR | 14172 |
19910 | 1 | NATEGLINIDE//MITIGLINIDE//REPAGLINIDE | 506 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | NATEGLINIDE | authKW | 3909876 | 20% | 61% | 103 |
2 | MITIGLINIDE | authKW | 2052950 | 8% | 80% | 41 |
3 | REPAGLINIDE | authKW | 2046641 | 18% | 36% | 91 |
4 | KAD 1229 | authKW | 871991 | 3% | 100% | 14 |
5 | A 4166 | authKW | 566226 | 2% | 91% | 10 |
6 | PRANDIAL GLUCOSE REGULATION | authKW | 420420 | 2% | 75% | 9 |
7 | GLINIDES | authKW | 327807 | 2% | 53% | 10 |
8 | 2S 2 BENZYL 3 CIS HEXAHYDROISOINDOLIN 2 YLCARBONYLPROPIONIC ACID | authKW | 186855 | 1% | 100% | 3 |
9 | POTENT HYPOGLYCEMIC EFFECT | authKW | 186855 | 1% | 100% | 3 |
10 | S 21403 | authKW | 186855 | 1% | 100% | 3 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 4949 | 38% | 0% | 193 |
2 | Pharmacology & Pharmacy | 1932 | 37% | 0% | 186 |
3 | Medicine, General & Internal | 82 | 8% | 0% | 38 |
4 | Medicine, Research & Experimental | 81 | 6% | 0% | 30 |
5 | Chemistry, Analytical | 75 | 7% | 0% | 34 |
6 | Biochemical Research Methods | 53 | 4% | 0% | 22 |
7 | Chemistry, Medicinal | 45 | 4% | 0% | 18 |
8 | Toxicology | 3 | 2% | 0% | 8 |
9 | Chemistry, Multidisciplinary | 2 | 5% | 0% | 24 |
10 | Geriatrics & Gerontology | 2 | 1% | 0% | 3 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PHARMACEUT REGULATORY AFFAIRS QUAL ASSURANCE DE | 140140 | 1% | 75% | 3 |
2 | AFFLIATED PEOPLE HOSP 6SHANGHAI DIABET | 62285 | 0% | 100% | 1 |
3 | BIOPHARMACEUT PHARMOKINET | 62285 | 0% | 100% | 1 |
4 | BUNDANGHOSP | 62285 | 0% | 100% | 1 |
5 | CARDIOVASC DIS ENDOCRINOL | 62285 | 0% | 100% | 1 |
6 | CARDIOVASC METAB ENDOCRINE | 62285 | 0% | 100% | 1 |
7 | CENT S LIFE SCI S | 62285 | 0% | 100% | 1 |
8 | CNRS UMR ENDOCRINOL MET CANC | 62285 | 0% | 100% | 1 |
9 | CVM CARDIOVASC METAB | 62285 | 0% | 100% | 1 |
10 | GERIAT MED METAB DIS 2 | 62285 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DIABETES OBESITY & METABOLISM | 6803 | 3% | 1% | 16 |
2 | DIABETES CARE | 4834 | 6% | 0% | 30 |
3 | JOURNAL OF DIABETES INVESTIGATION | 4667 | 1% | 1% | 7 |
4 | DIABETES RESEARCH AND CLINICAL PRACTICE | 4521 | 4% | 0% | 20 |
5 | DIABETIC MEDICINE | 2723 | 3% | 0% | 16 |
6 | ENDOCRINE JOURNAL | 2527 | 2% | 0% | 11 |
7 | EXPERT OPINION ON PHARMACOTHERAPY | 2513 | 2% | 0% | 11 |
8 | DIABETES & METABOLISM | 2146 | 2% | 0% | 10 |
9 | EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 2141 | 2% | 0% | 9 |
10 | ACTA DIABETOLOGICA | 1856 | 1% | 0% | 7 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NATEGLINIDE | 3909876 | 20% | 61% | 103 | Search NATEGLINIDE | Search NATEGLINIDE |
2 | MITIGLINIDE | 2052950 | 8% | 80% | 41 | Search MITIGLINIDE | Search MITIGLINIDE |
3 | REPAGLINIDE | 2046641 | 18% | 36% | 91 | Search REPAGLINIDE | Search REPAGLINIDE |
4 | KAD 1229 | 871991 | 3% | 100% | 14 | Search KAD+1229 | Search KAD+1229 |
5 | A 4166 | 566226 | 2% | 91% | 10 | Search A+4166 | Search A+4166 |
6 | PRANDIAL GLUCOSE REGULATION | 420420 | 2% | 75% | 9 | Search PRANDIAL+GLUCOSE+REGULATION | Search PRANDIAL+GLUCOSE+REGULATION |
7 | GLINIDES | 327807 | 2% | 53% | 10 | Search GLINIDES | Search GLINIDES |
8 | 2S 2 BENZYL 3 CIS HEXAHYDROISOINDOLIN 2 YLCARBONYLPROPIONIC ACID | 186855 | 1% | 100% | 3 | Search 2S+2+BENZYL+3+CIS+HEXAHYDROISOINDOLIN+2+YLCARBONYLPROPIONIC+ACID | Search 2S+2+BENZYL+3+CIS+HEXAHYDROISOINDOLIN+2+YLCARBONYLPROPIONIC+ACID |
9 | POTENT HYPOGLYCEMIC EFFECT | 186855 | 1% | 100% | 3 | Search POTENT+HYPOGLYCEMIC+EFFECT | Search POTENT+HYPOGLYCEMIC+EFFECT |
10 | S 21403 | 186855 | 1% | 100% | 3 | Search S+21403 | Search S+21403 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |